Myeloma Institute Videos

Why should I be treated at an academic medical center?
What do I need to know about multiple myeloma?
Drug Trial for Castleman’s Gets Amazing Results
Why should I travel to Arkansas to be treated for multiple myeloma?
Andy Shapira - A Patient Testomonial
David Fajgenbaum Survivor Story
My advice to myeloma patients
UAMS -- Cancer and Myeloma Treatment -- Sean's Story

Patient Power Videos

Our mission is to fortify the health care consumer with the knowledge and tools to feel more confident playing a central role in decisions that affect their health, putting them more in control of their health and health care.  To especially empower patients and families dealing with cancer and serious, life-long chronic conditions so their “journey” can be better. View Patient Power videos featuring Dr. Morgan and Dr. Davies.

Living Well With Multiple Myeloma
A Town Meeting for Patients, Care Partners and Families
@University of Arkansas for Medical Sciences (UAMS)

Expert Perspective: Optimizing Care Through Clinical Trials for Myeloma
Expert Perspective: Maximizing and Understanding Myeloma Treatment Approaches
Inspiring and Encouraging Words From a Myeloma Survivor
Morning Session
Afternoon Session
Care Partner Support: Working Together as a Couple
An Explanation of Myeloma
Choosing Treatment for YOUR Myeloma
Transplant as an Effective Treatment for Multiple Myeloma
How Oncology Social Workers Can Help
How to Take of Yourself and Prevent Infection With Myeloma
An Expert Explains Why to Consider a Myeloma Clinical Trial
Where Does Immunotherapy Fit in With Myeloma Treatment?
Myeloma Remission: Managing Life After Treatment
Should Multiple Myeloma Patients Undergo Genetic Testing?

Video Journal of Hemalotogical Oncology

The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers. Website

Myeloma 2016: Panel discussion on the status of genomics
Myeloma 2016: Panel discussion on the new treatment paradigm
The mechanisms driving relapse in multiple myeloma
The clinical implications of progenitor cells in multiple myeloma
Identification of high-risk disease using molecular profiling by Mymap
The FORTE clinical trial of carfilzomib in multiple myeloma
The future of multiple myeloma treatment
Utilizing new understanding in multiple myeloma biology to guide treatment
Is FISH becoming obsolete in multiple myeloma?
Treatment at first relapse in multiple myeloma: how to choose a drug?
An all-molecular diagnostic approach for myeloma
The importance of the microenvironment in multiple myeloma
Update on trametinib for multiple myeloma
Novel kinase targets as emerging therapies for multiple myeloma
Are we ready for mutational directed treatment: addressing the genomic basis of myeloma
Frontline treatment for young multiple myeloma patients